Commercial Eyes P/L for Dainippon Sumitomo Pharma Ltd
1 PBAC submission on file, first appeared 2015. 0% have been recommended.
Submissions
1
2015 → 2015
Win rate
0 %
0 recommended of 1 bucketable
Drugs
1 · 0 listed
unique molecules submitted
PBS spend captured
—
FY-latest govt benefit on owned drugs
Drug portfolio
Sorted by PBS spend captured. PBS expenditure is credited to the sponsor with the most recent Recommended decision per drug, so biosimilars and originator brands aren't double-counted.